Deep sleep could be key to forestalling slow declines in brain health that may one day lead to Alzheimer's disease, the most common form of dementia.
Topline data from the pivotal INFRONT-3 Phase 3 clinical trial of latozinemab in FTD-GRN expected by Q4 2025Anticipate completing enrollment in ...
Protein accumulations do important work in the human body, but something can go wrong and proliferate in those aggregates, ...
Researchers at Washington University in St. Louis have found a critical role for the physical interfaces of these of amyloid beta peptides in determining the chemical dynamics of their assemblies ...
When people have Alzheimer’s disease, their brains slowly accumulate abnormal clumps of two proteins: amyloid and tau. At ...
With early diagnosis of Alzheimer's disease comes the possibility of treatment to not only help manage symptoms but also slow ...
Rapid Enrollment and Dosing of First Patients Encouraging and Underscores Unmet Need for Better Treatment Options for Alzheimer’s Disease ...
In “Doctored,” Charles Piller uncovers evidence that many important Alzheimer’s studies are based on faulty data.
New research has revitalized interest in the longstanding link between brain trauma and dementia by focusing on the vascular ...
ScienceAlert on MSN2d
A Man Fated to Get Alzheimer's Avoided It For Decades. But How?In an exceptionally rare case, a patient with a high genetic risk of developing Alzheimer's appears to have avoided his ...
A new biomarker test can detect early-stage tau protein clumping up to a decade before it appears on brain scans, improving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback